The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia

Por Crisan, AM, Coriu, D, Arion, C, Colita, A, Jardan, C
Publicado no J Med Life (2015)

The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression – an overlapping myeloproliferative disorder or two distinct diseases? - case rep...

Por Ursuleac, I, Colita, AC, Adam, T, Jardan, C, Ilea, A, Coriu, D
Publicado em 2013

The simultaneous occurrence of multiple myeloma and JAK2 positive myeloproliferative neoplasms - Report on two cases

Por Badelita, S, Dobrea, C, Colita, A, Dogaru, M, Dragomir, M, Jardan, C, Coriu, D
Publicado no J Med Life (2015)